Transplant referral patterns for patients (pts) with newly diagnosed (ND) higher-risk (HR) myelodysplastic dyndromes (MDS), and European leukemianet (ELN) 2010 intermediate-tisk (IR) or adverse-risk (AR) acute myeloid leukemia (AML) in the Connect® MDS/AML registry

Authors

Benjamin Tomlinson
Marcos de LimaFollow
Christopher R. CogleFollow
Michael A. Thompson, Advocate Aurora HealthFollow
David L. Grinblatt
Daniel A. Pollyea
Rami Komrokji
Gail J. Roboz
Michael R. Savona
Mikkael A. Serkeres
E Dawn Flick
Pavel Kiselev
Chrystal U. Louis
Melissa Nifenecker
Arlene S. Swern
Harry P. Erba
David P. Steensma
Bart L. Scott

Recommended Citation

Tomslinson B, de Lima M, Cogle CR, Thompson MA, Grinblatt DL, Pollyea DA, Komrokji R, Roboz GJ, Savona MR, Sekeres MA, Flick ED, Kiselev P, Louis CU, Nifenecker M, Swern AS, Erba HP, Steensma DP, Scott BL. Transplant referral patterns for patients (pts) with newly diagnosed (ND) higher-risk (HR) myelodysplastic dyndromes (MDS), and European leukemianet (ELN) 2010 intermediate-tisk (IR) or adverse-risk (AR) acute myeloid leukemia (AML) in the Connect® MDS/AML registry. Biology of blood and marrow transplantation. 2020;26(S3):S98-S99. doi: 10.1016/j.bbmt.2019.12.599.

Affiliations

Aurora Research Institute, Advocate Aurora Health

Document Type

Abstract